Evidence Amyloid Scan EEG Study

UnknownOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

November 15, 2020

Study Completion Date

November 30, 2020

Conditions
Alzheimer DiseaseDementia FrontalMild Cognitive Impairment
Interventions
DEVICE

EEG scan

WAVi EEG and evoked potential platform. Participants will be scanned using the ElectroCap (FDA Class II) and/or the WAVi Headset with the WAVi Co EEG P300 system, along with the structured clinical interviews and assessments for the various ailments or baseline screenings

Trial Locations (1)

77036

RECRUITING

Translational Cognitive Research, Houston

Sponsors
All Listed Sponsors
collaborator

Institute of Asian American Adult Development

UNKNOWN

lead

Metabolic Therapy Inc.

OTHER